QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)

NRx Pharmaceuticals - NRXP Stock Forecast, Price & News

$1.23
-0.02 (-1.60%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.18
$1.26
50-Day Range
$1.01
$1.48
52-Week Range
$0.49
$3.54
Volume
246,822 shs
Average Volume
338,708 shs
Market Capitalization
$83.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

NRx Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
143.9% Upside
$3.00 Price Target
Short Interest
Healthy
3.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Balanced
Insiders Both Buying and Selling
Proj. Earnings Growth
Growing
From ($0.67) to ($0.62) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

162nd out of 1,055 stocks

Pharmaceutical Preparations Industry

73rd out of 519 stocks


NRXP stock logo

About NRx Pharmaceuticals (NASDAQ:NRXP) Stock

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Receive NRXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRXP Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
NRx Receives Nasdaq Notice of Listing Compliance
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Earnings Outlook For NRX Pharmaceuticals
NRx Pharmaceuticals, Inc. (NRXP)
NRX Pharmaceuticals Inc.
/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
NRx Pharmaceuticals names new CEO
See More Headlines
Receive NRXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRXP Company Calendar

Last Earnings
11/14/2022
Today
1/27/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NRXP
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+143.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-93,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.35 per share

Miscellaneous

Free Float
50,294,000
Market Cap
$83.26 million
Optionable
Not Optionable
Beta
0.97

Key Executives

  • Stephen H. Willard
    Chief Executive Officer & Director
  • Robert Besthof
    Chief Commercial Officer & Head-Operations
  • Seth L. van Voorhees
    Chief Financial Officer & Treasurer
  • Carrie M. Carretta
    Senior VP-Clinical Development & Medical Affairs
  • Dennis K. McBride
    Chief Strategy Officer













NRXP Stock - Frequently Asked Questions

Should I buy or sell NRx Pharmaceuticals stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NRx Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NRXP shares.
View NRXP analyst ratings
or view top-rated stocks.

What is NRx Pharmaceuticals' stock price forecast for 2023?

2 Wall Street analysts have issued 12-month target prices for NRx Pharmaceuticals' shares. Their NRXP share price forecasts range from $2.00 to $4.00. On average, they anticipate the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 140.0% from the stock's current price.
View analysts price targets for NRXP
or view top-rated stocks among Wall Street analysts.

How have NRXP shares performed in 2023?

NRx Pharmaceuticals' stock was trading at $1.11 on January 1st, 2023. Since then, NRXP shares have increased by 12.6% and is now trading at $1.25.
View the best growth stocks for 2023 here
.

When is NRx Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our NRXP earnings forecast
.

How were NRx Pharmaceuticals' earnings last quarter?

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) posted its quarterly earnings results on Monday, November, 14th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14).

What is NRx Pharmaceuticals' stock symbol?

NRx Pharmaceuticals trades on the NASDAQ under the ticker symbol "NRXP."

Who are NRx Pharmaceuticals' major shareholders?

NRx Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Exchange Traded Concepts LLC (0.04%). Insiders that own company stock include Alessandra Daigneault, Chaim Hurvitz, Daniel C Javitt, Jonathan C Javitt, Patrick John Flynn, Robert Besthof, Stephen H Willard and Voorhees Seth Van.
View institutional ownership trends
.

How do I buy shares of NRx Pharmaceuticals?

Shares of NRXP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NRx Pharmaceuticals' stock price today?

One share of NRXP stock can currently be purchased for approximately $1.25.

How much money does NRx Pharmaceuticals make?

NRx Pharmaceuticals (NASDAQ:NRXP) has a market capitalization of $84.61 million. The company earns $-93,060,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

How can I contact NRx Pharmaceuticals?

NRx Pharmaceuticals' mailing address is 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483. The official website for the company is www.bigrockpartners.com. The company can be reached via phone at (484) 254-6134 or via email at rsheffield@nrxpharma.com.

This page (NASDAQ:NRXP) was last updated on 1/27/2023 by MarketBeat.com Staff